Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program

By afschroeder • October 28, 2025

Herman WH, Tyndall BD, Duru OK, Moin T, McEwen LN, Shao H, Ackermann RT, Jacobs SR, Neuwahl S, Kuo S, Zhang P, Pavkov ME, Villatoro Santos C; REALITY Network. Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program. AJPM Focus. 2025 Jul 29;4(6):100401. doi: 10.1016/j.focus.2025.100401. PMID: 41141958; PMCID: PMC12550230.

Tags: cost-effectiveness, diabetes prevention, Endocrinology, lifestyle change programs, MOVE!, National Diabetes Prevention Program, prediabetes, Publications

Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents

Wang SY, Stofer R, Wang H, Brent GA, Shi L, Cai Y, Roosan M, Moin T. Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist[...]

Impact of a Nurse Practitioner-Led Diabetes Program on Barriers to CGM Use in a Federally Qualified Health Center After Medicaid Expansion

Scarlett LD, Solorzano W, Khoshbin K, Villanueva GP, Mangual KS, Tavares M, Santana C, Escobar B, Borrell J, Brumley B, Moin T, Everett E. Impact[...]

Immune Checkpoint Inhibitor-Associated Uveitis: Predictors and Survival Impact

Chew L, Feng J, Hutchins E, Stein-Merlob AF, Yang EH, Lechner MG, Tsui E. Immune Checkpoint Inhibitor-Associated Uveitis: Predictors and Survival Impact. Ophthalmol Retina. 2025[...]